Adaptimmune Therapeutics PLC (ADAP)
0.6048
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
0.5958
-0.01
(-1.49%)
After-Hours: 20:00
Adaptimmune Therapeutics Price to Free Cash Flow
Price to Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Cash Flow Definition
Price to free cash flow measures the Price / TTM Free Cash Flow. Like other price ratios (ie. PE Ratio, PS Ratio, P/B Ratio), this metric can be used to compare companies with similar capital structures. Free cash flow gives an idea of how much cash is available for shareholders through stock buybacks and dividend payouts. A lower price to free cash flow is more desirable when assessing different companies.
Price to Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median